List of insiders holdings for Tarsus Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| RTW INVESTMENTS LP WONG RODERICK 10% Owner | 2024-02-14 07:28:27 | 3,152,341 0 | 3,152,341 | Form 13G |
| Horowitz Limited Partnership VIII 10% Owner | 2020-10-30 17:00:52 | 1,987,105 0 | 1,987,105 | Form 13D |
| Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N Heron Patrick J 10% Owner | 2024-11-06 10:26:57 | 1,587,527 0 | 1,587,527 | Form 13G |
| Azamian Bobak R. President/CEO and Board Chair | 2024-03-19 19:05:06 | 99,980 830,106 | 930,086 | Form 4 |
| Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner | 2024-02-13 17:03:50 | 894,826 0 | 894,826 | Form 13G |
| LINK WILLIAM J PHD Director | 2024-08-14 16:34:26 | 194,214 85,338 | 279,552 | Form 4 |
| Farrow Jeffrey S See Remarks | 2024-06-20 16:26:33 | 101,780 0 | 101,780 | Form 4 |
| Neervannan Seshadri Chief Operating Officer | 2024-03-19 19:03:19 | 99,405 0 | 99,405 | Form 4 |
| Mottiwala Aziz Chief Commercial Officer | 2024-03-19 19:08:33 | 88,099 0 | 88,099 | Form 4 |
| Wahl Bryan General Counsel | 2024-03-19 19:05:51 | 72,276 0 | 72,276 | Form 4 |
| Lin Elizabeth Yeu Chief Medical Officer | 2024-11-06 16:40:29 | 68,352 0 | 68,352 | Form 4 |
| Whitfield Dianne C. Chief Human Resources Officer | 2024-03-19 19:04:16 | 64,851 0 | 64,851 | Form 4 |
| Greenstein Leonard M. Chief Financial Officer | 2023-04-21 17:53:14 | 26,785 0 | 26,785 | Form 4 |
| Tester Jason E. Director 10% Owner | 2021-06-17 19:26:49 | 20,000 0 | 20,000 | Form 4 |
| Ackermann Michael Director | 2022-07-01 12:31:58 | 19,000 0 | 19,000 | Form 4 |
| Goodrich Katherine Director | 2024-11-15 16:37:08 | 16,700 0 | 16,700 | Form 4 |
| YARNO WENDY L Director | 2024-06-25 18:21:55 | 10,350 0 | 10,350 | Form 4 |
| Goldberg Andrew D. Director | 2024-06-25 18:26:18 | 6,350 0 | 6,350 | Form 4 |
| Morrison Scott W Director | 2024-10-02 17:27:04 | 0 6,016 | 6,016 | Form 4 |
| CHAUDHURI BHASKAR Director | 2024-06-25 18:22:23 | 5,350 0 | 5,350 | Form 4 |
| Crane Rosemary A Director | 2024-06-25 18:26:45 | 5,350 0 | 5,350 | Form 4 |
| Holdbrook Mark J. V.P., Clinical Affairs | 2023-03-21 19:06:38 | 3,191 0 | 3,191 | Form 4 |
| Trevejo Jose M. CHIEF MEDICAL OFFICER | 2023-12-22 17:32:52 | 2,251 0 | 2,251 | Form 4 |